Advertisement

Ontogeny of Thyroid during Embryogenesis: Evidence of Two Thyroxine Binding Sites

  • Diego Bellabarba
  • Serge Belisle
  • Nicole Gallo-Payet
  • Jean-Guy Lehoux

Abstract

Evidences gathered over the past ten years indicate that triiodothyronine (T3) is the thyroid hormone responsible for the metabolic effect (1). However, there are particular situations in which little or no T3 is produced by the organism and, therefore, it is not clear how the thyroid action will be expressed. One of these situations is the fetal or neonatal period, in humans and in various experimental animals. Very low amounts of T3 are produced during this time, since the 5’-monodeiodinase is not yet fully developed (2–4). Therefore, thyroxine (T4) is the only thyroid hormone present in large quantities during a period of great hormonal need because of the rapid maturation of several target tissues. Such a situation is particularly evident in chick embryo where most of the target organs, particularly the nervous system, develop between 7–12 days (5), when the concentration of T3 in the serum is very low (6).

Keywords

Thyroid Hormone Chick Embryo Scatchard Plot Maximal Binding Capacity Rapid Maturation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Oppenheimer JH. Science 203: 971, 1979.PubMedCrossRefGoogle Scholar
  2. 2.
    Fisher DA, Dussault JH, Sack J, et al. Rec Prog Horm 33: 59, 1972.Google Scholar
  3. 3.
    Dubois JD and Dussault JH. Endocrinology 101: 435, 1975.CrossRefGoogle Scholar
  4. 4.
    Borges M, Labourene J, and Ingbar SH. Endocrinology 107: 1751, 1980.PubMedCrossRefGoogle Scholar
  5. 5.
    Hanaway J. J Comp Neurol 131: 1, 1967.PubMedCrossRefGoogle Scholar
  6. 6.
    Millette F, Lehoux JG, and Bellabarba D. Endocrinology 108: 254, 1981.CrossRefGoogle Scholar
  7. 7.
    Silva ES, Astier H, Thakare U, et al. J Biol Chem 248: 7066, 1977.Google Scholar
  8. 8.
    Bellabarba D and Lehoux JG. Endocrinology 109: 1017, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    Rodbard D. Adv Exp Med Biol 36: 289, 1973.PubMedCrossRefGoogle Scholar
  10. 10.
    Giles KW and Myers A. Nature 206: 93, 1965.CrossRefGoogle Scholar
  11. 11.
    Galton VA and Schaafsma J. Endocrinology 112: 1999, 1983.Google Scholar
  12. 12.
    Moriya T, Thomas CR, and Frieden E. Endocrinology 114: 170, 1984.CrossRefGoogle Scholar
  13. 13.
    Margarity M, Matsokis N, and Valcana T. Mol Cel Endocrinol 31: 333, 1983.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Diego Bellabarba
    • 1
  • Serge Belisle
    • 1
  • Nicole Gallo-Payet
    • 1
  • Jean-Guy Lehoux
    • 1
  1. 1.Laboratoire d’Endocrinologie, Department de Medecine d’Obstetrique et Gynecologie et de BiochimieFaculte de Medecine, Universite de SherbrookeSherbrookeCanada

Personalised recommendations